Shane Kapral reports Rule 144/10b5-1 sales

Shane Kapral reported proposed sales of Common stock under Rule 144 and 10b5-1 plans.

Rhea-AI Filing Summary

Shane Kapral reported proposed sales of Common stock under Rule 144 and 10b5-1 plans. The filing lists multiple 10b5-1 sale entries dated from 12/01/2025 through 02/17/2026 showing per-transaction numeric lines such as 12/01/2025: 254 / 48976.28 and 02/17/2026: 616 / 128134.16.

The entries appear in a Rule 144 notice format and enumerate previously executed 10b5-1 sales and restricted stock unit details; timing and numeric lines are presented verbatim in the excerpt.

Insights

Corporate Governance Specialist

Routine Rule 144/10b5-1 activity by an officer is disclosed; transactions are listed by date and numeric lines.

The excerpt lists multiple 10b5-1 sale entries attributed to Shane Kapral, with dates from 12/01/2025 to 02/17/2026. Each line shows two numeric fields as presented in the source (for example, 02/17/2026: 616 / 128134.16).

These entries are routine disclosure of planned or executed insider sales under Rule 144 and 10b5-1; subsequent filings may provide transaction-level settlement details or exact share counts in conventional labels.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TKO Form 144 filed by Shane Kapral disclose?

It discloses multiple proposed or executed sales under Rule 144 and 10b5-1 plans. The excerpt lists sale entries dated from 12/01/2025 to 02/17/2026, with numeric lines shown verbatim alongside each date.

Does the excerpt show the dates of Shane Kapral's sales for TKO?

Yes. The filing lists transaction dates between 12/01/2025 and 02/17/2026. Specific dated entries include 12/01/2025, 01/05/2026, and 02/17/2026 as examples.

Are the amounts or share counts clearly labeled in the TKO excerpt?

The excerpt presents numeric pairs beside each date but does not label them with explicit field names. Examples include entries such as 254 / 48976.28 and 616 / 128134.16 as shown in the text.

Is this Form 144 filing an indication of insider selling activity at TKO?

Yes; the filing enumerates multiple 10b5-1 sales associated with Shane Kapral, indicating insider selling activity. The records are presented as a sequence of dated sale lines in the excerpt.

Who is the reporting person named in the excerpt for TKO transactions?

The reporting person shown is Shane Kapral, with an address listed as 200 Fifth Ave, 7th Floor, New York, NY 10010. Multiple entries in the excerpt are attributed to that name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001992689
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TKO GROUP HOLDINGS, INC.
SEC File Number	001-41797
Address of Issuer	200 Fifth Ave, 7th Floor New York NEW YORK 10010
Phone	6465588333
Name of Person for Whose Account the Securities are To Be Sold	SHANE KAPRAL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	616	130049.92	78922362	02/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2025	Restricted Stock Units	Issuer			616	12/31/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	02/17/2026	616	128134.16
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	02/09/2026	616	130308.64
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	02/02/2026	616	124456.64
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	01/27/2026	615	124668.19
SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	01/22/2026	1238	250051.24
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	01/20/2026	613	124911.01
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	01/12/2026	749	148925.93
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	01/07/2026	224	45129.28
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	01/05/2026	253	51877.65
SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	01/05/2026	1693	345507.44
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	12/29/2025	253	54739.08
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	12/22/2025	254	54376.32
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	12/15/2025	254	52435.76
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	12/08/2025	254	51412.14
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	12/01/2025	254	48976.28
10b5-1 Sales for SHANE KAPRAL 200 Fifth Ave, 7th Floor New York NY 10010	Common	11/24/2025	254	45293.28

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 12/31/2025 through 1/20/2026
Date of Notice	02/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Shane Kapral
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)